Your browser doesn't support javascript.
loading
Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities.
Wang, Meng; Rieber, Lila; van Baaren, Jessica; Morgan, Meaghan; Merrett, Stephanie; McDowell, Ian; Bowen, Tyson.
Afiliação
  • Wang M; UCB Biosciences Inc, Early Solutions, Cambridge, Massachusetts, USA.
  • Rieber L; UCB Biosciences Inc, Early Solutions, Durham, North Carolina, USA.
  • van Baaren J; UCB Biosciences Inc, Early Solutions, Cambridge, Massachusetts, USA.
  • Morgan M; UCB Biosciences Inc, Early Solutions, Durham, North Carolina, USA.
  • Merrett S; UCB Biosciences Inc, Early Solutions, Durham, North Carolina, USA.
  • McDowell I; UCB Biosciences Inc, Early Solutions, Durham, North Carolina, USA.
  • Bowen T; UCB Biosciences Inc, Early Solutions, Durham, North Carolina, USA.
CRISPR J ; 7(2): 120-130, 2024 04.
Article em En | MEDLINE | ID: mdl-38635326
ABSTRACT
CRISPR-Cas systems have proven effective in a variety of applications due to their ease of use and relatively high editing efficiency. Yet, any individual CRISPR-Cas system has inherent limitations, necessitating a diversity of RNA-guided nucleases to suit applications with distinct needs. We searched through metagenomic sequences to identify RNA-guided nucleases and found enzymes from diverse CRISPR-Cas types and subtypes, the most promising of which we developed into gene-editing platforms. Based on prior annotations of the metagenomic sequences, we establish the likely taxa and sampling locations where Class 2 CRISPR-Cas systems active in eukaryotes may be found. The newly discovered systems show robust capabilities as gene editors and base editors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Revista: CRISPR J Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Idioma: En Revista: CRISPR J Ano de publicação: 2024 Tipo de documento: Article